Peter Lindgren
- Economics and Econometrics top 0.5%
- Health Systems, Economic Evaluations, Quality of Life 87
- Pharmaceutical Economics and Policy 31
- Economic and Financial Impacts of Cancer 13
- Healthcare Policy and Management 10
-
- Multiple Sclerosis Research Studies 12
-
- Antiplatelet Therapy and Cardiovascular Diseases 14
- Geriatrics and Gerontology top 5%
- Family Practice top 5%
-
- Lipoproteins and Cardiovascular Health 26
-
- Chronic Disease Management Strategies 10
- Co-authors
- Bengt JönssonGisela KobeltJenny BergNils WilkingThomas HofmarcherErik LandfeldtAnna RingborgHanns Lochmüller
- Cited by
- Economics and EconometricsPathology and Forensic MedicineCardiology and Cardiovascular Medicine
- Journals
- The European Journal of Health Economics (21 papers)Value in Health (15 papers)PharmacoEconomics (6 papers)
- Partner nations
- SwedenUnited KingdomUnited States
In The Last Decade
Peter Lindgren
170 papers receiving 4.2k citations
Peers
Comparison fields: 5 of 158
- Economics and Econometrics 1.6k
- Pathology and Forensic Medicine 709
- Cardiology and Cardiovascular Medicine 832
- Geriatrics and Gerontology 116
- Family Practice 54
Countries citing papers authored by Peter Lindgren
This map shows the geographic impact of Peter Lindgren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Lindgren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Lindgren more than expected).
Fields of papers citing papers by Peter Lindgren
This network shows the impact of papers produced by Peter Lindgren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Lindgren. The network helps show where Peter Lindgren may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Lindgren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 3 | |
| 5 | 2022 | 4 | |
| 6 | 2021 | 2 | |
| 7 | 2020 | 12 | |
| 8 | 2019 | 9 | |
| 9 | 2017 | 13 | |
| 10 | 2016 | 4 | |
| 11 | 2016 | 2 | |
| 12 | 2016 | 13 | |
| 13 | 2016 | 17 | |
| 14 | Business Model Innovation with the NEFFICS platform and VDML | 2013 | 3 |
| 15 | 2012 | 6 | |
| 16 | 2012 | 16 | |
| 17 | Abstract 1349: The Economic Consequences of Non-Adherence to Lipid-Lowering Therapy: Results From the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) | 2009 | 1 |
| 18 | Once-daily extended release quetiapine fumarate (quetiapine XR) as adjunct to) antidepressant therapy fit patients with major depressive disorder | 2008 | 4 |
| 19 | 2006 | 48 | |
| 20 | 2003 | 6 |
About Peter Lindgren
Peter Lindgren is a scholar working on Economics and Econometrics, Cardiology and Cardiovascular Medicine, Family Practice, Pathology and Forensic Medicine and Psychiatry and Mental health, having authored 181 papers that have together received 4.4k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (87 papers), Pharmaceutical Economics and Policy (31 papers), Lipoproteins and Cardiovascular Health (26 papers), Antiplatelet Therapy and Cardiovascular Diseases (14 papers), Economic and Financial Impacts of Cancer (13 papers), Multiple Sclerosis Research Studies (12 papers), Chronic Disease Management Strategies (10 papers) and Healthcare Policy and Management (10 papers). The work is most often cited by research in Economics and Econometrics (1.6k citations), Pathology and Forensic Medicine (709 citations), Cardiology and Cardiovascular Medicine (832 citations), Geriatrics and Gerontology (116 citations) and Family Practice (54 citations). Peter Lindgren has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Bengt Jönsson, Gisela Kobelt, Jenny Berg, Nils Wilking, Thomas Hofmarcher, Erik Landfeldt, Anna Ringborg, Hanns Lochmüller, Volker Straub and Linus Jönsson. Their work appears in journals such as The European Journal of Health Economics, Value in Health, PharmacoEconomics, Clinical Therapeutics and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.